After some early setbacks, AbbVie has scored a second straight victory in its AndroGel legal saga. On Friday, a federal jury sided with the drugmaker over plaintiff Robert Nolte and his legal team, ...

Are you a male experiencing symptoms of low testosterone such as weight gain and a high-pitched voice? If so, you may want to look into a product by the name of AndroGel. This testosterone gel has ...

ATLANTA (CN) - Drugmakers cannot dismiss antitrust claims stemming from their multimillion-dollar settlements to eliminate competing generic drugs, a federal judge ruled. In the 1990s, Solvay ...

AbbVie has suffered its second big AndroGel loss in court. On Thursday, a federal jury ordered the drugmaker to pay more than $140 million to a plaintiff who had a heart attack on the testosterone med ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

AbbVie notched a win late last month in its ongoing battle against thousands of lawsuits that claim AndroGel, a once-blockbuster drug marketed to treat low testosterone in men, causes heart attacks, ...

WASHINGTON, Sept 8 (Reuters) - The U.S. Federal Trade Commission on Monday sued Drugmakers AbbVie Inc and Teva Pharmaceuticals Industries Ltd for allegedly illegally preventing generic versions of ...

In a split decision, a federal jury in Chicago ordered AbbVie to pay $150 million in punitive damages for fraudulently misrepresenting the risks of its AndroGel testosterone replacement drug. But at ...

July 5 (Reuters) - A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone ...

The FDA has approved AndroGel (testosterone gel; Abbott) 1.62% for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone, including ...

Five years after the U.S. Supreme Court found in FTC v. Actavis, 570 U.S. 136 (2013), that large and unjustified payments from a brand pharmaceutical manufacturer to prevent generic entry can provide ...

(Reuters) - A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug ...